文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

SLC31A1 Identifying a Novel Biomarker with Potential Prognostic and Immunotherapeutic Potential in Pan-Cancer.

作者信息

Zhang Pei, Yang Heqi, Zhu Kaiguo, Chang Chen, Lv Wanrui, Li Ruizhen, Li Xiaoying, Ye Tinghong, Cao Dan

机构信息

Division of Abdominal Tumor Multimodality Treatment, Cancer Center, West China Hospital, Sichuan University, No. 37 Guoxue Alley, Chengdu 610041, China.

Sichuan University-Oxford University Huaxi Gastrointestinal Cancer Centre, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.

出版信息

Biomedicines. 2023 Oct 25;11(11):2884. doi: 10.3390/biomedicines11112884.


DOI:10.3390/biomedicines11112884
PMID:38001885
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10669416/
Abstract

Solute carrier family 31 member 1 () encodes a protein that functions as a homotrimer for the uptake of dietary copper. As a vital member of the cuproptosis gene family, it plays an essential role in both normal tissues and tumors. In this study, we analyzed across human cancer types to gain a better understanding of 's role in cancer development. We searched for information using online databases to analyze, systematically and comprehensively, the role of in tumors. Amongst nine cancer types, the expression of was significantly different between tumors and normal tissues. According to further analysis, pancreatic cancer had the highest mutation rate of the gene, and the methylation levels of the gene were significantly reduced in seven tumors. The expression of is also linked to the infiltration of tumors by immune cells, the expression of immune checkpoint genes, and immunotherapy markers (TMB and MSI), suggesting that may be of particular relevance in immunotherapy. This thorough analysis of across different types of cancer gives us a clear and comprehensive insight into its role in causing cancer on a systemic level.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d633/10669416/22a02d78c9d8/biomedicines-11-02884-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d633/10669416/4ab8fc58b596/biomedicines-11-02884-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d633/10669416/ea3903c3ab5b/biomedicines-11-02884-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d633/10669416/738f74613c50/biomedicines-11-02884-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d633/10669416/fb6e731ecaa7/biomedicines-11-02884-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d633/10669416/e0c2073c7c31/biomedicines-11-02884-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d633/10669416/5b5c286fab26/biomedicines-11-02884-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d633/10669416/3f2994f384e1/biomedicines-11-02884-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d633/10669416/22a02d78c9d8/biomedicines-11-02884-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d633/10669416/4ab8fc58b596/biomedicines-11-02884-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d633/10669416/ea3903c3ab5b/biomedicines-11-02884-g002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d633/10669416/738f74613c50/biomedicines-11-02884-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d633/10669416/fb6e731ecaa7/biomedicines-11-02884-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d633/10669416/e0c2073c7c31/biomedicines-11-02884-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d633/10669416/5b5c286fab26/biomedicines-11-02884-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d633/10669416/3f2994f384e1/biomedicines-11-02884-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d633/10669416/22a02d78c9d8/biomedicines-11-02884-g008.jpg

相似文献

[1]
SLC31A1 Identifying a Novel Biomarker with Potential Prognostic and Immunotherapeutic Potential in Pan-Cancer.

Biomedicines. 2023-10-25

[2]
Elucidating cuproptosis-related gene SLC31A1 diagnostic and prognostic values in cancer.

Am J Transl Res. 2023-10-15

[3]
Systematic pan-cancer analysis identifies SLC31A1 as a biomarker in multiple tumor types.

BMC Med Genomics. 2023-3-27

[4]
Comprehensive analysis of the effects of the cuprotosis-associated gene on patient prognosis and tumor microenvironment in human cancer.

Transl Cancer Res. 2024-2-29

[5]
Cuproptosis-related gene SLC31A1: prognosis values and potential biological functions in cancer.

Sci Rep. 2023-10-18

[6]
Revealing the potential of solute carrier family 31 (copper transporters), member 1: Insights into its role in bladder cancer progression and therapeutic implications.

Int J Immunopathol Pharmacol. 2024

[7]
Identification of cuproptosis-related gene SLC31A1 and upstream LncRNA-miRNA regulatory axis in breast cancer.

Sci Rep. 2023-10-26

[8]
High expression of cuproptosis-related SLC31A1 gene in relation to unfavorable outcome and deregulated immune cell infiltration in breast cancer: an analysis based on public databases.

BMC Bioinformatics. 2022-8-22

[9]
Cuproptosis-related gene SLC31A1 is a potential predictor for diagnosis, prognosis and therapeutic response of breast cancer.

Am J Cancer Res. 2022-8-15

[10]
A ceRNA network-mediated over-expression of cuproptosis-related gene SLC31A1 correlates with poor prognosis and positive immune infiltration in breast cancer.

Front Med (Lausanne). 2023-5-18

引用本文的文献

[1]
Immune profiling in oncology: bridging the gap between technology and treatment.

Med Oncol. 2025-8-26

[2]
Single-cell RNA sequencing reveals SLC31A1-mediated M2 polarization of macrophages promotes malignant progression in triple-negative breast cancer.

J Cancer Res Clin Oncol. 2025-5-14

[3]
Plasma IgG and IgM autoantibodies to COPT1 as potential biomarkers for detection of non-small cell lung cancer.

Front Immunol. 2025-4-11

[4]
Copper homeostasis and copper-induced cell death in tumor immunity: implications for therapeutic strategies in cancer immunotherapy.

Biomark Res. 2024-10-31

[5]
New BDNF and NT-3 Cyclic Mimetics Concur with Copper to Activate Trophic Signaling Pathways as Potential Molecular Entities to Protect Old Brains from Neurodegeneration.

Biomolecules. 2024-9-2

[6]
Pan-cancer analysis reveals copper transporters as promising potential targets.

Heliyon. 2024-8-27

[7]
The Effect of Cuproptosis-Related Proteins on Macrophage Polarization in Mesothelioma is Revealed by scRNA-seq.

Biol Trace Elem Res. 2025-4

[8]
Exploring Novel Frontiers in Cancer Therapy.

Biomedicines. 2024-6-18

[9]
Bioinformatics analysis and experimental validation of m6A and cuproptosis-related lncRNA NFE4 in clear cell renal cell carcinoma.

Discov Oncol. 2024-5-26

[10]
Computational Characterization of Membrane Proteins as Anticancer Targets: Current Challenges and Opportunities.

Int J Mol Sci. 2024-3-26

本文引用的文献

[1]
Cuproptosis-related gene SLC31A1 expression correlates with the prognosis and tumor immune microenvironment in glioma.

Funct Integr Genomics. 2023-8-23

[2]
Systematic pan-cancer analysis identifies SLC31A1 as a biomarker in multiple tumor types.

BMC Med Genomics. 2023-3-27

[3]
High expression of cuproptosis-related SLC31A1 gene in relation to unfavorable outcome and deregulated immune cell infiltration in breast cancer: an analysis based on public databases.

BMC Bioinformatics. 2022-8-22

[4]
Copper induces cell death by targeting lipoylated TCA cycle proteins.

Science. 2022-3-18

[5]
Correlation of CCL8 expression with immune cell infiltration of skin cutaneous melanoma: potential as a prognostic indicator and therapeutic pathway.

Cancer Cell Int. 2021-11-29

[6]
A Pilot Study Analyzing the Clinical Utility of Comprehensive Genomic Profiling Using Plasma Cell-Free DNA for Solid Tumor Patients in Japan (PROFILE Study).

Ann Surg Oncol. 2021-12

[7]
BIRC5 is a prognostic biomarker associated with tumor immune cell infiltration.

Sci Rep. 2021-1-11

[8]
Overview of New Treatments with Immunotherapy for Breast Cancer and a Proposal of a Combination Therapy.

Molecules. 2020-12-2

[9]
The Human Protein Atlas-Spatial localization of the human proteome in health and disease.

Protein Sci. 2021-1

[10]
Targeted Therapy Recommendations for Therapy Refractory Solid Tumors-Data from the Real-World Precision Medicine Platform MONDTI.

J Pers Med. 2020-10-23

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索